Original NEXUS Contract - Laserfiche WebLink

Home Browse Search

Attachment 1 UW Research Subaward Agreement Prime Award Terms and Conditions The Prime Award Terms and Conditions contained in this Attachment are modified to the extent where applicable as follows: • "Award" shall mean "Subaward"; • "Recipient" shall mean "Subrecipient"; ■ "CDC' shall mean "University of Washington" This Agreement is subject to the following terms and conditions: Notice of Funding Opportunity (NOFO): PS19-1909 Award Number: NU65PS923685-02 Award Type: Cooperative Agreement Applicable Regulations: 45 Code of Federal Regulations (CFR) Part 75, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for HHS Awards AWARD INFORMATION Incorporation: In addition to the federal laws, regulations, policies, and CDC General Terms and Conditions for Non -research awards at blips://www.cdc.gov/grants/fadorairegiifationspoiicies/index.iitm1, the Centers for Disease Control and Prevention (CDC) hereby incorporates Notice of Funding Opportunity (NOFO) number PS19-1909, entitled National Harm Reduction Technical Assistance and Syringe Services Program (SSP) Monitoring and Evaluation, and application dated June 24, 2019, as may be amended, which are hereby made a part of this Non -research award, hereinafter referred to as the Notice of Award (NoA). Financial Assistance Mechanism: Cooperative Agreement Substantial Involvement by CDC: This is a cooperative agreement and CDC will have substantial programmatic involvement after the award is made. Substantial involvement is in addition to all post -award monitoring, technical assistance, and performance reviews undertaken in the normal course of stewardship of federal funds. CDC program staff will assist, coordinate, or participate in carrying out effort under the award, and recipients agree to the responsibilities therein, as detailed in the NOFO. In a cooperative agreement, CDC staff are substantially involved in the program activities, above and beyond routine grant monitoring. CDC activities for this program are as follows: 1. Foster communication, coordination and collaboration between awardees working under the components and demonstration projects. 2. Work with recipients to identify and address challenges that may impede the success of the project. Recipients must work with the assigned CDC project officer, and other subject matter 3. Provide access to technical guidance and training that will strengthen awardee capacity relevant to implementation of all required activities of the program. 4. Provide software and/or programming support to collect data from SSPs, SSP clients, and drug -using peers of SSP clients 5. Provide guidance to awardees on data collection, use, and submission for monitoring and evaluation activities. 6. Facilitate coordination, collaboration, and where feasible, integration of technical assistance services among CDC -funded programs (i.e., health departments, CBOs, local and state planning groups, CPN members); other federal agencies and their recipients; and other partners working with persons with opioid use disorder and persons who inject drugs. 7. Provide technical guidance to recipients to improve the quality and effectiveness of work plans, evaluation strategies, products and services, and collaborative activities with other organizations. 8. Collaborate in assessing measurable progress toward meeting program outcomes and in Page 1 of 4